Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor M6620 in Treating Patients With Metastatic Urothelial Cancer

  • Peng Wang

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleCisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor M6620 in Treating Patients With Metastatic Urothelial Cancer
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsPeng Wang